Kyrgyzstan vs Saint Vincent and the Grenadines: Statin use vs. average non-HDL cholesterol levels
Statin use vs. average non-HDL cholesterol levels over time
- Kyrgyzstan
- Saint Vincent and the Grenadines
How they compare
Kyrgyzstan currently reports 3.2 against 3.2 in Saint Vincent and the Grenadines, a difference of 0.
The two have swapped places 1 time across 39 shared years of data; in 1980 it was Kyrgyzstan ahead.
Kyrgyzstan ranks 118th and Saint Vincent and the Grenadines ranks 118th of 191 countries.
Across the 4 decades both report, Kyrgyzstan averaged higher in 1 and Saint Vincent and the Grenadines in 2.
Head to head by decade
| Decade | Kyrgyzstan | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.1 | 3.06 | 0.04 | Kyrgyzstan |
| 1990s | 3.1 | 3.1 | 0 | — |
| 2000s | 3.1 | 3.16 | 0.06 | Saint Vincent and the Grenadines |
| 2010s | 3.16 | 3.2 | 0.0444 | Saint Vincent and the Grenadines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs. average non-hdl cholesterol levels, Kyrgyzstan or Saint Vincent and the Grenadines?
- Kyrgyzstan, at 3.2 against 3.2 in Saint Vincent and the Grenadines as of 2018.
- What is the difference in statin use vs. average non-hdl cholesterol levels between Kyrgyzstan and Saint Vincent and the Grenadines?
- 0, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Saint Vincent and the Grenadines?
- 39 years are reported by both, from 1980 to 2018.
- How do Kyrgyzstan and Saint Vincent and the Grenadines rank globally for statin use vs. average non-hdl cholesterol levels?
- Kyrgyzstan ranks 118th and Saint Vincent and the Grenadines ranks 118th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Statin use vs. average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.